MORRISVILLE, NC (March 9, 2009) —
the pioneer in drug verification and safety, announced today a successful launch of its new website that will focus
on its flagship product, PASS Rx at www.centice.com or www.passrx.com.
The new website was developed with concise navigation in mind for pharmacy professionals to explore how PASS Rx will
benefit them and their patients directly, whether they are a pharmacist, technician or business executive in retail,
hospital, government or mail order pharmacies. The site emphasizes how easy it is to implement and use the PASS Rx
Increased script volume, fewer resources, and manual subjective methodologies can unfortunately result in greater risk
for pharmaceutical dispensing errors. Traditionally, pharmacists have relied on largely subjective manual checks based
on visual appearance. PASS Rx is the first and only product for the pharmacy that utilizes patented molecular and
machine vision sensor technologies to confirm the accuracy of a pharmacy’s dispensed pharmaceutical in a matter of
“The launch of our new website will help to get the word out about the availability and benefits of PASS Rx,” said Ray
W. Swanson, President and CEO of Centice. “We are very excited to provide our customers with a new venue to learn
more about PASS Rx and how the system can benefit their pharmacy by increasing their patients’ safety, improving the
quality control process and overall workflow efficiency,” he added.
In addition to product information and demonstration video, the site provides information about Centice, its history
and technology, applications where PASS Rx can be implemented, a customer spotlight, recent news, future event
schedule, and convenient options for prospects and customers to contact sales or service.
Centice Corporation’s efforts support President Barack Obama’s Plan for a Healthy America, where ensuring patient
safety and quality care are top priority. PASS Rx is an option that addresses this plan to reduce and report on
preventable medical errors.
About Centice Corporation
Centice, founded in 2004 and headquartered in RTP, NC, is commercializing patented and patent-pending computational
sensor and machine vision technology. The PASS Rx® pharmaceutical authentication sensor system improves the
verification process for dispensed medications, thereby increasing efficiency and optimizing workflow in the
pharmacy. The company has received venture capital investments from The Aurora Funds, Inc., Novak Biddle Venture
Partners, S-Group Direct Investments Ltd, Innovation Ventures LP, and other private investors. More information on
Centice can be found at http://www.centice.com.